Pyrotinib is a small-molecule tyrosine kinase inhibitor (TKI) categorized as a targeted antineoplastic agent, primarily indicated for the treatment of HER2-positive breast cancer.
What Kind of Drug is Pyrotinib?
Update: 19 Jan,2026 Source: Haiou Health Views: 132
